Neuroscience

Articles and news from the latest research reports.

352 notes

Addiction starts with an overcorrection in the brain
The National Institutes of Health has turned to neuroscientists at the nation’s most “Stone Cold Sober” university for help finding ways to treat drug and alcohol addiction.
Brigham Young University professor Scott Steffensen and his collaborators have published three new scientific papers that detail the brain mechanisms involved with addictive substances. And the NIH thinks Steffensen’s on the right track, as evidenced by a $2-million grant that will help fund projects in his BYU lab for the next five years.
“Addiction is a brain disease that could be treated like any other disease,” Steffensen said. “I wouldn’t be as motivated to do this research, or as passionate about the work, if I didn’t think a cure was possible.” 
Steffensen’s research suggests that the process of a brain becoming addicted is similar to a driver overcorrecting a vehicle. When drugs and alcohol release unnaturally high levels of dopamine in the brain’s pleasure system, oxidative stress occurs in the brain.
Steffensen and his collaborators have found that the brain responds by generating a protein called BDNF (brain derived neurotrophic factor). This correction suppresses the brain’s normal production of dopamine long after someone comes down from a high. Not having enough dopamine is what causes the pains, distress and anxiety of withdrawal.
“The body attempts to compensate for unnatural levels of dopamine, but a pathological process occurs,” Steffensen said. “We think it all centers around a subset of neurons that ordinarily put the brakes on dopamine release.”
A group of undergraduate students work in Steffensen’s lab along with post-doctoral fellows and graduate students. Jennifer Blanchard Mabey, a graduate student in neuroscience, co-authored a paper about withdrawal that is in the current issue of The Journal of Neuroscience.
“It’s rewarding to see that your research efforts place another small piece in the enormous addiction puzzle,” said Mabey.
A separate study, co-authored by Steffensen and Ph.D. candidates Nathan Schilaty and David Hedges, explains how nicotine and alcohol interact in the brain.
“Addiction is a huge concern in our society and is very misunderstood,” Schilaty said. “Our research is helping us to formulate ideas on how we can better help these individuals through non-invasive and non-pharmacological means.”
Eun Young Jang, a post-doctoral fellow in Steffensen’s lab, authored a third paper for Addiction Biology describing the effects of cocaine addiction on the brain’s reward circuitry.
In these three research papers, dopamine is the common thread.
“I am optimistic that in the near future medical science will be able to reverse the brain changes in dopamine transmission that occur with drug dependence and return an ‘addict’ to a relatively normal state,” Steffensen said. “Then the addict will be in a better position to make rational decisions regarding their behavior and will be empowered to remain drug free.”

Addiction starts with an overcorrection in the brain

The National Institutes of Health has turned to neuroscientists at the nation’s most “Stone Cold Sober” university for help finding ways to treat drug and alcohol addiction.

Brigham Young University professor Scott Steffensen and his collaborators have published three new scientific papers that detail the brain mechanisms involved with addictive substances. And the NIH thinks Steffensen’s on the right track, as evidenced by a $2-million grant that will help fund projects in his BYU lab for the next five years.

“Addiction is a brain disease that could be treated like any other disease,” Steffensen said. “I wouldn’t be as motivated to do this research, or as passionate about the work, if I didn’t think a cure was possible.” 

Steffensen’s research suggests that the process of a brain becoming addicted is similar to a driver overcorrecting a vehicle. When drugs and alcohol release unnaturally high levels of dopamine in the brain’s pleasure system, oxidative stress occurs in the brain.

Steffensen and his collaborators have found that the brain responds by generating a protein called BDNF (brain derived neurotrophic factor). This correction suppresses the brain’s normal production of dopamine long after someone comes down from a high. Not having enough dopamine is what causes the pains, distress and anxiety of withdrawal.

“The body attempts to compensate for unnatural levels of dopamine, but a pathological process occurs,” Steffensen said. “We think it all centers around a subset of neurons that ordinarily put the brakes on dopamine release.”

A group of undergraduate students work in Steffensen’s lab along with post-doctoral fellows and graduate students. Jennifer Blanchard Mabey, a graduate student in neuroscience, co-authored a paper about withdrawal that is in the current issue of The Journal of Neuroscience.

“It’s rewarding to see that your research efforts place another small piece in the enormous addiction puzzle,” said Mabey.

A separate study, co-authored by Steffensen and Ph.D. candidates Nathan Schilaty and David Hedges, explains how nicotine and alcohol interact in the brain.

“Addiction is a huge concern in our society and is very misunderstood,” Schilaty said. “Our research is helping us to formulate ideas on how we can better help these individuals through non-invasive and non-pharmacological means.”

Eun Young Jang, a post-doctoral fellow in Steffensen’s lab, authored a third paper for Addiction Biology describing the effects of cocaine addiction on the brain’s reward circuitry.

In these three research papers, dopamine is the common thread.

“I am optimistic that in the near future medical science will be able to reverse the brain changes in dopamine transmission that occur with drug dependence and return an ‘addict’ to a relatively normal state,” Steffensen said. “Then the addict will be in a better position to make rational decisions regarding their behavior and will be empowered to remain drug free.”

Filed under addiction brain-derived neurotrophic factor opiates dopamine neuroscience science

  1. loganshoutsnever reblogged this from xshelbyjanex
  2. xshelbyjanex reblogged this from neurosciencestuff
  3. circlenowsquared reblogged this from neurosciencestuff
  4. voidrager reblogged this from neurosciencestuff
  5. krst05 reblogged this from neurosciencestuff
  6. lostlyricalmess reblogged this from neurosciencestuff
  7. midgetmonkey reblogged this from neurosciencestuff
  8. abstractnerd reblogged this from neurosciencestuff
  9. ddeadcode reblogged this from neurosciencestuff
  10. inthemorningdarkness reblogged this from neurosciencestuff
  11. pugglenurse reblogged this from nursingfinds
  12. brewngames reblogged this from neurosciencestuff
  13. reginadentata reblogged this from ms-kawesome
  14. microbiomusings reblogged this from neurosciencestuff
  15. wvr1975 reblogged this from neurosciencestuff
  16. raskolnika reblogged this from neurosciencestuff
  17. sheepinlove reblogged this from neurosciencestuff
  18. ute-to-be reblogged this from neurosciencestuff
  19. oh-jamespotter reblogged this from neurosciencestuff
  20. bangzedrumz reblogged this from princessuterus
  21. princessuterus reblogged this from oursavioryeezus
  22. euphorialborealis reblogged this from neurosciencestuff
  23. pieace reblogged this from shedangerous
  24. shedangerous reblogged this from uglylittlepoopheart
free counters